Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 7, 2020, after the close
10-Q filed May 7, 2020, 37 days after period end · 0000320017-20-000036
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | — | — | — | $7.92M |
| Net Income | -$3.99M | -$4.37M | -$4.98M | -$9.79M |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.38 |
| -$0.44 |
| -$0.52 |
| -$1.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
